).
I. Introduction
The last decades have witnessed an upsurge of neuropeptides research. These substances regulate or influence various functions in the body like appetite, water intake, learning and memory, adaptive responses to environmental stress, thermoregulation and fever, social behaviour, and sleep. One function may be regulated by several peptides, and a single peptide can be involved in different functions -a general approach is to find a coordinated physiological pattern, which appears "meaningful" in explaining how a given peptide may participate in complex physiological events.
Kisspeptin (formerly known as metastin) is a protein that is encoded by the KISS1 gene in the Anteroventral periventricular nucleus (AVPV) and Arcuate nucleus (ARC) nuclei of the hypothalamus, coupled to G-protein receptor ligand for (GPR54) G-protein receptor 54 . Kisspeptins are also described as excitatory neuromodulatory peptides for multiple homeostatic systems including initiation of puberty, anti-oxidative effect, regulation of prolactin release, glucose homeostasis, role in nutrition status and fertility, role in pregnancy, increases sensitivity of chemoreceptors on type 2 carotid bodies, anti-metastatic effect, hot flushes in post-menopausal women. Kisspeptin is localized in the central nervous system like the hypothalamus (mainly the AVPV and ARC nuclei), pituitary (Kotani et al, 2001 ), cerebellum, cerebral cortex, thalamus and Pons-medulla (Muir et al, 2001 ) and moderately expressed in the Peripheral body organs; like the testes, pancreas, liver, small intestine, and also the placenta (Ohtaki et al, 2001 ). The Kiss1 gene was originally identified as a human metastasis suppressor gene because of its ability to suppress melanoma and breast cancer metastasis (Lee et al, 1996) . The primary translation product of the kisspeptin gene is a 145-amino acid protein (Kisspeptin-145) (Xanvier and William, 2010). The kisspeptin-145 design predisposes its peptides for proteosome degradation and shows that cytosolic KP-145 would have a short half-life of about 4 days (Mitchell et al, 2006) . Proteolytic cleavage of the precursor protein (kisspeptin-145) generates a 54-amino acid amidated peptide (Kp54), and over time, shorter kisspeptins have been isolated (Kp14 and Kp13), which are degradative products from Kp54, the shortest kisspeptins degradative product is the kisspeptin-10 (Kp10) (Xanvier and William, 2010) . Kisspeptins are so named because the arginine-phenylalanine residues are present at the amino terminal "Arg-Phe-NH2"; all of the kisspeptin fragments have a C-terminal decapeptide that is critical for biological activity (Clements et al, 2001 ; Kotani et al, 2001 ). Kisspeptins are an overlapping set of amidated peptides encoded by the Kiss1 gene. The KISS1 gene is located in close proximity to the Golt1a gene (golgi transport 1 homolog A gene). The SP1 transcription factor has a zinc finger protein design, by which it binds directly to DNA and enhances gene transcription (Park et al, 2002) . (These SP1 binding sites facilitate binding of AP-1/ SP1 and DRIP130/SP1 transcriptional activator complexes and contribute to basal promoter activity). Two SP1 binding site closest to the transcriptional site on the kisspeptin gene function together to facilitate transcriptional activation by estrogen (Xanvier and William, 2010). As in the figure above, the kisspeptin coding region (pale blue) is located within two exons of the Kiss1 gene, in this diagram, one upstream non-coding exon (white) has been identified and the promoter (P1) in humans had been mapped immediately upstream of this exon (Xanvier and William, 2010). The primary translation gene product is a 145-amino acid protein (Kisspeptin-145), which contains a secretory signal sequence (dark green as in the diagram above) (Xanvier and William, 2010). The full-length KP protein (KP-145) has a PEST sequence (proline, glutamic acid, serine, threonine and aspartic acid residue-rich sequence). Its design predisposes proteins for proteosome degradation and suggests that cytosolic KP-145 would have a short half-life of about 4 days (Kotani et al, 2001) . Proteolytic cleavage of the precursor protein (kisspeptin-145) generates a 54-amino acid amidated peptide (Kp54), over time, shorter kisspeptins have been isolated (Kp14 and Kp13), which are degradative products from Kp54 (Xanvier and William, 2010). KP-54, the long isoform of kisspeptin in human, cleaved from the amidated KP-145 precursor by the action of the enzyme furin/prohormone convertases (Kotani et al, 2001; Ohtaki et al, 2001; Harms et al, 2003) . In rat and mouse, the long kisspeptin isoform is 52 amino acids long, with Arg-Try-NH2 at the C terminus instead of ArgPhe-NH2 as in humans (Tena-Sempere, 2006).
Biochemistry of Kisspeptins
The KiSS-1 gene encodes a large polypeptide consisting of 145 amino acids, known as the pre-peptide to kisspeptins (precursor protein) i.e. kisspeptin 145 (Takino et al, 2003) . The precursor protein is cleaved to form kisspeptin-54 (metastin) which is further cleaved to equally potent smaller fragments of 14, 13 and 10 amino acids in length. These fragments have subsequently been shown to bind and activate GPR-54 with equal potency (Kotani et al, 2001) . The final 10 amino acid fragment of the C-terminus has been used to determine the structure of Kisspeptins by nuclear magnetic resonance spectroscopy (NMR). Two studies have used NMR to determine the structure;
 The first used sodium dodecyl sulphate (SDS) micelles NMR method, which represents a negatively charged membrane. In this study kisspeptin-13 was utilised and residues Asn7 to Phe13 were found to form a stable helix structure (Takino et al, 2003) .
 The second study utilised dodecylphosphocholine (DPC) micelles NMR mechanism which represent a membrane with a neutral charge, similar to the mammalian lipid membrane. Using kisspeptin-10, they showed that Trp3 to Phe10 contained several tight turn structures but no helices. The tight turns contained one β-turn from Tyr3 to Phe6; two miscellaneous type IV β-turns at Asn4 to Gly7 and Gly7 to Phe10; and finally one γ-turn from Ser5 to Gly7 (Lee et al, 1999) . This suggests that hydrophobic environments may cause Kisspeptins to form a more ordered structure allowing them to bind and activate GPR-54. The use of NMR to determine the structure of kisspeptin fragments has also shown that hydrogen bonds are important within these peptides, with eight hydrogen bonds being formed within Kisspeptin-13, allowing 16 hydrogen constraints. These are formed between residues Phe9, Leu11, Arg12 and Phe13. These four residues have also been shown to form a pharmacophore which is important for receptor binding. The pharmacophore consists of the phenyl ring of Phe9 with the Phe13 phenyl ring on top. These are then flanked by the positively charged Arg12, which is all in close proximity to the amide moiety. Even though the pharmacophore residues can form hydrogen bonds, it appears that the positive charge is more important for receptor binding (Takino et al, 2003) . All kisspeptins fragments have also been shown to contain a matrix metalloproteinase (MMP) mediated cleavage site, which is thought to be a mechanism to inactivate the protein. This site is at the C-terminus consisting of Phe-Gly-Leu-Arg, were MMP-2 and MMP-9 can cleave kisspeptin-54 between Gly51 and Leu52 (Takino et al, 2003) . 
III.

Mechanism of Action
Receptors and second messenger
The kisspeptin receptor was initially classified as an orphan receptor, also known as GPR54 (G-protein coupled receptor 54); GPR54 is a member of the GPCR family member, was found to be the cognate receptor for kisspeptin five years after the hormone (kisspeptin) was first described (Kotani et al, 2001; Muir et al, 2001; Ohtaki et al, 2001 ) and is widely expressed in the central nervous system especially in the nuclei of the hypothalamus mainly AVPV (Anteroventral periventricular nucleus) and ARC (Arcuate nucleus) (Lee et al, 1999) . G protein-coupled receptors (GPCRs) are the largest family of cell surface membrane receptors and regulate a variety of physiological responses by mediating transmission of extracellular signals into cells (Lee et al, 1999) . The kisspeptin receptor (GPR54/KISS1R) is a member of the rhodopsin family of seven transmembrane GPRs with structural similarities to the galanin receptor (Lee et al, 1999) . Lee et al, (1999) cloned a novel G-protein-coupled receptor from rat brain and identified it (G-protein-coupled receptor) as a 396-amino acid polypeptide. The kisspeptin receptor is a class A G-protein-coupled receptor coupled to G q/11 , causing activation of the phospholipase C signaling pathway and resultant Ca 2+ mobilization. Rat and human kisspeptin receptors share 85% sequence identity (Thompson et al, 2006) . The closest structural relative of the kisspeptin receptor is the galanin receptor GAL 1 with 45% homology; however galanin does not bind to it. KP-10, consisting of the 10 C-terminal amino acids of the full sequence, is the minimum fragment length needed to bind and activate the kisspeptin receptor (Lee et al, 1999) .
Activation of the kisspeptin receptor by kisspeptins causes phosphorylation of focal adhesion kinase and paxillin, leading to formation of focal adhesion and stress fibers (Kotani et al, 2001; Ohtaki et al, 2001) , and this correlates with the role of kisspeptin in inhibiting chemotaxis. Kisspeptin receptor stimulation has been demonstrated to inhibit calcineurin activity, which could also contribute to metastasis suppression (Navenot et al, 2005) . GPR54/KISS1R (kisspeptin recetor) causes the depolarization of neuron through activating a cascade system by employing the phospholipase C-second messenger system. Kisspeptin binding to its receptor (GPR54/KISS1R) activates the G-protein (G q/11 ) and phospholipase C to cleave phosphatidylinositol biphosphate (PIP 2 ) into inositol triphosphate (IP3) and diacylglycerol (DAG) (Xanvier and William, 2010). IP3 causes intracellular Ca 2+ release from the mitochondria and endoplasmic reticulum, this Ca 2+ ions act through the calcium-calmodulin second messenger system to cause activation of calmodulin-dependent protein kinases through phosphorylation. One specific function of calmodulin is to activate myosin light-chain kinase, which acts directly on the myosin of smooth muscle to cause smooth muscle contraction (Guyton and Hall, 12 th edition).
Diacylglycerol (DAG) activates protein kinase C and a kinase phosphorylation cascade resulting in the release of arachidonic acid and stimulation of the mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK) 1 and ERK2 kinase (Kotani et al, 2001 ). This has been attributed to increased phosphorylation of mitogen-activated protein kinase (MAPK). Additionally, other kinases are reported to be activated by KISS1 including myeloid cell leukemia 1, calcium/calmodulin-dependent kinases and tyrosine kinases (Becker et al, 2005) in the cytosol, which causes the breakdown of a large number of proteins in an array such that a very little amount of the hormone (kisspeptin) will cause a strong effect on the target organ (Xanvier and William, 2010) as seen in the Fig 3 above . DAG also stimulates GnRH neuron depolarization by activation of a nonselective cation channel (TRPC) and inhibition of an inwardly rectifying potassium channel (Kir) (Xanvier and William, 2010). Therefore kisspeptins act directly on GnRH neurons to induce a sustained depolarization event and increase the rate of action potential firing (Xanvier and William, 2010).
Metabolism
Kisseptin is metabolized by the prolyl endopeptidase (PREP) also known as post-proline cleaving enzyme, which is a large cytosolic enzyme that belongs to a distinct class of serine peptidases. Endopeptidase-24.15 cleaves several substrates found in the hypothalamic/pituitary/gonadal axis, including gonadotropinreleasing hormone (GnRH) and the opioid peptides of the dynorphin family; thereby causing the Dynorphin unit of the KNDy to cause decrease in kisspeptin expression in the hypothalamus (Yamada et al., 2007) . A developmental regulation of EP-24.15-specific activity is apparent in anterior pituitary, hypothalamus, and in the gonads. EP-24.15 is increased in the preoptic area and is decreased in the anterior pituitary in both male and female rats prior to puberty (Pierotti et al, 1985) .
IV. Physiology of Kisspeptin Puberty Initiation
Puberty is the onset of adult sexual life occurring in both males and females, it is the process of physical changes in which the body matures into an adult body capable of sexual reproduction, and it is also a period of mental transition. The period of puberty is caused by a gradual increase in gonadotrophic hormones such as follicular stimulating hormone (FSH) and lutenizing hormone (LH) secreted by the pituitary to the gonads (the ovaries in female and the testis in males), beginning averagely at about 8 years, and usually culminating in the onset of puberty and menstruation between ages 11 and 16 years in females, averagely at 13 years and between 13 to 17 years in males, averagely at 14 years (Guyton and Hall, 12 th edition). The hypothalamus does not secrete significant quantities of GnRH during childhood as studies have shown that the hypothalamus itself is capable of secreting these reproductive hormone such as follicular stimulating hormone(FSH), but the appropriate signal from some other area of brain in the hypothalamus to cause the secretion is lacking (Messenger et al 2005) . Stimulatory signals originating from the circadian clock in the suprachiasmatic nucleus (SCN) mediate the LH surge by activating kisspeptin neuron mainly in the Anteroventral periventricular nucleus (AVPV) (Wilbur et al, 2011) .
Kisspeptin has since been identified as a major regulator of the hypothalamic-pituitary-gonadal axis (HPG), governing pubertal onset in an increasing number of species, by stimulating gonadotropin release (Dhillo et al, 2005; . The activity of the HGP axis (the hypothalamic-pituitary-gonadal axis) is heighten by the release of kisspeptin into the body. Therefore during the initiation of puberty, the kisspeptin produced in the AVPV (Anteroventral periventricular nucleus) and ARC (arcuate nucleus) in the hypothalamus trigger the GnRH neurons to secrete GnRH (Gonadotrophin releasing hormone). The gonadotrophin releasing hormone travels down the anterior portion of the pituitary via the hypophyseal portal system and binds to receptors on the secretory cells of the adenohypophysis (Charlton, 2008) . In response to GnRH stimulation these cells (cells of the adenohypophysis) produce LH (lutenizing hormone) and FSH (follicular stimulating hormone) which travel in the blood stream (Vadakkadath, 2005). These two hormones play an important role in communicating with the gonads, which therefore leads to an increase in the gonadal hormones such as testosterone and estrogen which will lead to the development of the physiological and behavioural changes in puberty (Meethal et al, 2009 ). Sex steroids (such as estrogen, testosterone and progesterone), Gonadotrophins (follicular stimulating hormone and lutenizing hormone) have been shown to affect behaviour, as these sex steroids and hormones affect the brain structure and functioning (Hines, 1982) . Estrogenic hormones binding to particular neurons in a limbic-hypothalamic system stimulate and cause changes on the molecular biology of medial hypothalamic neurons which are central in establishing the first circuit for a mammalian behaviour, for instance, in the femaletypical mating behaviour, "lordosis", estradiol has the ability to facilitate transcription from six genes whose products are important for lordosis behaviour . This proves that sex steriods can turn on genes which are associated with sensible behavioural consequences (Pfaff et al, 2000) . Testosterone levels which rise as a result of increased GnRH due to release of kisspeptin from the hypothalamic neurons, have been shown to relate to aggression and sex drive, testosterone creates synaptogenesis by promoting neurite development and migration, therefore men tend to be more competitive or aggressive than women (Shephard, 2009).
In females FSH (follicle-stimulating hormone) and LH (lutenizing hormone) act primarily to activate the ovaries to produce estrogen and to regulate the menstrual cycle and ovarian cycle (Meethal et al, 2009 ).
In males lutenizing hormone (LH) stimulates the interstitial cells located in the testes to produce testosterone, and follicle-stimulating hormone (FSH) plays a role in spermatogenesis (Meethal et al, 2009 ). At birth follicle-stimulating hormone (FSH) and lutenizing hormone (LH) levels are elevated, and the females have a lifetime supply of primary oocytes; these hormonal levels (FSH and LH) decrease and remain low through childhood. During puberty the HPG axis is activated by the secretions of estrogen from the ovaries or testosterone from the testes (Downs, 2009 ). Once activated, the HPG axis continues to function in men for the rest of their life but becomes deregulated in women, leading to menopause. This deregulation is caused mainly by the lack of oocytes that normally produce estrogen to create the positive feedback loop; over several years, the activity the HPG axis decreases and women are no longer fertile (Downs, 2009 ).
Sex steroids (estrogen, progesterone, androgen and testosterone) provide feedback loops that allow the gonads to communicate with the hypothalamus to regulate GnRH release. This regulatory/feedback effect of the sex steroid was found to be in association with kisspeptin (Xanvier and William, 2010), therefore an investigation of the epigenetic mechanism by which sex steroids (mainly estrogen) regulates the expression of the kisspeptin-encoding gene (Kiss1) to mediate the positive feedback effect of kisspeptin on GnRH release was carried out; Fig. 4 (a) shows the result of the investigation of the epigenetic mechanism by which estrogen regulates the expression of the kisspeptin-encoding gene Kiss1 to mediate its positive feedback effect on GnRH release (Junko et al, 2012).
As in the figure above, the Kiss1 gene looping induced by estrogen stimulation in the AVPV, it shows two possible states of the mouse Kiss1 gene locus during transcriptional regulation in the AVPV. (Upper) In the absence of estrogen, a factor-mediated association between the Kiss1 promoter and the 5′ upstream region forms a chromatin loop (a chromatin loop occurs when stretches of genomic sequence that lie on the same chromosome are in closer physical proximity to each other than to intervening sequences) which will prevent transcription. (Lower) In the presence of estrogen, the estrogen-ERα complex induces histone acetylation in the Kiss1 promoter region, causing a relaxed chromatin structure and consequently enhances the formation of a chromatin loop between the Kiss1 promoter and the 3′ enhancer region, promoting transcription; this indicates that only in the presence of estrogen does kiss1 promoter enhance the transcription of the KISS1 gene which induces GnRH surges by acting on the kisspeptin neurons in the AVPV to release kisspeptin molecules that activate GnRH neurons in the preoptic area of the hypothalamus (Junko et al, 2012) . The number of (GnRH) neurons that can respond to kisspeptins increases during puberty even though the expression levels only change slightly, suggesting posttranslational maturation of GPR54/KISS1R function with puberty control by the master clock of the body, the suprachiasmatic nucleus (SCN) of the hypothalamus (Moore et al, 1987) . The ERα-expressing neurons (α-isoform of the estrogen receptor) which are expressed within the AVPV are direct targets of the SCN (Palm et al, 1999) . One primary neuro-anatomical observation leading to the identification of the KNDy subpopulation was that; each of the component neuropeptides (kisspeptin, Neurokinin B, and Dynorphin A), when examined in dual-label studies showed a very high degree of colocalization with gonadal hormone steroid receptors, specifically the α-isoform of the estrogen receptor (ERα), the progesterone receptors (PR), and the androgen receptor (Xanvier and William, 2010). Because colocalization of the three KNDy peptides in the ARC appears to be unique among brain areas, colocalization of multiple KNDy peptides in the same axon terminal can be used to determine the efferent targets of this subpopulation; using this approach, it was demonstrated in the human that KNDy cells provide direct inputs to GnRH neurons in the pre-optic area (POA) and median eminence (ME) at the level of their cell bodies and dendrites showing that kisspeptin, NKB, and DYN fibers directly contact GnRH at the level of their cell bodies and their neuro-secretory terminals in the median eminence (Dahl et al, 2009 ). Based on observations, it has been proposed that synchronous activity of KNDy neurons is controlled by stimulatory actions of NKB and inhibitory actions of DYN on these KNDy neurons and their output to GnRH neurons is primarily via kisspeptin. Each GnRH pulse is triggered by an initial increase in NKB from a few KNDy neurons, which stimulates further NKB release; the resulting positive feedback loop produces release of kisspeptin onto GnRH neurons and hence an extremely rapid increase in GnRH secretion that occurs at the onset of a pulse. The positive feedback of NKB on the KNDy neurons also stimulate release of DYN, and the inhibitory actions of this DYN on KNDy neurons first begins to hold kisspeptin release in check and, after a few minutes, completely suppresses the activity of KNDy neurons, terminating the GnRH secretory episode and preventing any GnRH secretion between pulses. The action of DYN on KNDy neurons will also suppress DYN release, which eventually allows increased firing and the NKB release that triggers the next GnRH pulse (Moenter et al, 1992) .
Although, there is also compelling evidence that changes in KNDy cells occur as a part of the process of normal aging in association with menopause as it has long been known that in the brains of postmenopausal women, there is selective hypertrophy of neurons of the arcuate nucleus of the human hypothalamus (Sheehan et al, 1996) . The important role that KNDy neurons appear to play in the control of the GnRH system is interesting in light of the history of reproductive neuroendocrinology. The ARC was the hypothalamic nucleus that Ernst Knobil and others originally identified as the site of the GnRH pulse generator and has long been considered a key locus in steroidal control of GnRH secretion (Sheehan et al, 1996) . Fig. 4 (d) shows the process involved in puberty initiation. As GnRH neurons are the final central pathway controlling the onset of puberty, Kisspeptin potently activates GnRH release via G protein-coupled receptor 54 (GPR54) (Xanvier and William, 2010). The GnRH acts on the anterior pituitary to stimulate the release of the gonadotrophic hormones, (luteinizing hormone (LH), and follicle stimulating hormone (FSH)). The gonadotrophic hormones act on the gonads (ovary and testes) to stimulate to produce sex steroids (testosterone in males and estrogen and progesterone in females), required for sexual maturation and gametogenesis (spermatogenesis in males and oogenesis in females) which is the maturation of accessory sex organs, and to provide hormonal feedback loops that regulate GnRH and gonadotrophic hormone (FSH and LH) release under different physiological conditions (Xanvier and William, 2010).
V.
Other Physiological roles
Anti-metastatic Effect
The KiSS-1 gene that encodes kisspeptins was first discovered as an anti-metastasis gene made from observations of an anti-metastatic effect of chromosome 6 in human melanoma cell lines (Becker et al, 2005; Takino et al, 2003) . However, mapping showed that this gene was in fact located on chromosome 1q32 (which is the chromosome upon which kiss1 gene is located), not chromosome 6 (Lee et al, 1996) . Tumor necrosis factor-alpha (TNFa) induces cancer development and metastasis, which is prominently achieved by nuclear factor-kappa (NF-kB) activation. TNFa-induced NF-kB activation enhances cellular mechanisms including proliferation, migration, and invasion. However studies conducted showed that KiSS1 suppresses the migration of breast cancer cells by inhibiting TNFa-induced NF-kB (nuclear factor-kappa) pathway and RhoA activation as KP10 inhibited TNFa-induced cell migration and RhoA GTPase activation, thus KiSS1 inhibits TNFainduced NF-kB activation via down-regulation of RhoA-mediated TNFa-induced NF-kB (nuclear factor-kappa) activation and suppression of breast cancer cell migration and invasion (Lee, 1996) and inhibits MMP-9 (matrix metalloprotease) expression by reduced NF-kB binding to the MMP9 promoter, to cause an inhibition of cell (Mitchell et al, 2006 ).
In Pregnancy: Implantation and Placentation
The human placenta has a high expression of both the KiSS-1 and GPR54 genes. Plasma kisspeptin levels increase several thousand folds in pregnancy. In the human placenta, KiSS-1 is located within the syncytiotrophoblast cells (Bilban et al, 2004) . The non-pregnant plasma kisspeptin is around 1.3 fmol/ml, this increases to ~1230 fmol/ml in the first trimester and rises to ~9590 fmol/ml at term, then after delivery returns to normal levels within 5 days suggesting the source of kisspeptin is the placenta (Bilban et al, 2004 ) and also suggests a role in implantation and placentation, therefore KiSS-1 appears to be a conserved regulator of placentation. The role of the Kisspeptin-10 has been shown to inhibit trophoblast migration without affecting proliferation as kisspeptin is also located in the trophoblast giant cells within the rat placenta. Trophoblast invasion is important to allow remodelling of the maternal arteries, to provide sufficient blood flow to the developing foetus (Bilban et al, 2004) .
Increases Sensitivity of Chemoreceptors on the Carotid Body
Immunohistochemistry revealed diffuse expression of kisspeptins and its receptor in type 1 cells of both human and rat carotid bodies. Immuno-stained cells were distributed both in the centre and in the periphery of the lobules of the Type 1 carotid bodies, conversely, no kisspeptins or its receptor immuno-stainings were observed in type II cells (Porzionato et al, 2008) . Kisspeptin and kisspeptin receptor were found to be expressed in glomic type I cells through immunohistochemistry. A glomus cell is a peripheral chemoreceptor, located in the carotid bodies and aortic bodies, which help the body, regulate breathing. The glomus cells have a high metabolic rate and good blood perfusion and thus are sensitive to changes in arterial blood gas tension. In the carotid body, glomic type I cells release many neurotransmitters and peptide neuromodulators that play a role in the regulation of chemoreceptor (Iturriaga et al, 2004) . Kisspeptins could also show trophic actions on glomic cells, in the pre-and postnatal periods the carotid body undergoes structural changes mediated by trophic factors, which include brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, ciliary neurotrophic factor, insulin-like growth factors-I and II, basic fibroblast growth factor, epidermal growth factor, transforming growth factor-alpha and -beta1, interleukin-1beta and -6, tumour necrosis factor-alpha, vascular endothelial growth factor, and endothelin-1 (ET-1) (Porzionato et al, 2008) . These structural changes include the carotid body volume increase, proliferation of type I, type II, endothelial and Schwann cells lining peripheral nerve fibers and increased number of synapses between type I and II cells (Porzionato et al, 2008) which enhances activity of chemoreceptor. Expressions of both KISS1 and KISS1R were also found in ganglion cells of the human and rat superior cervical ganglia showing a role of kisspeptins in the modulation of the sympathetic function, mainly through autocrine or paracrine mechanisms.
Role in Nutritional Status and Fertility
It has long been recognized that an intimate relationship exists between nutritional status and fertility. Leptin, a peptide hormone synthesized and secreted by adipocytes conveying information about body energy stores and nutritional status and regulates appetite for food in humans (Zhang et al, 1994) . The level of circulating leptin is proportional to fat mass and falls in both animals and humans following weight loss. Mice with low circulating leptin have delayed puberty and are infertile as a consequence of hypogonadotrophic hypogonadism. Also, in an experiment, leptin was administered to juvenile wild-type mice; this led to the acceleration of puberty (Chehab et al, 1996) . In the type II diabetes, which causes obesity and hypogonadism is common, disturbed kisspeptin function can be rescued by leptin (Castellano et al, 2006) . The link between leptin and kisspeptin was further strengthened by observations that leptin can influence the expression of kisspeptin in the arcuate nucleus of mice, as the Kiss1 neurons express leptin receptors. Fig. 5 shows the potential mechanisms for transmitting the actions of leptin, produced by the white adipose tissue (WAT) to GnRH neurons in the basal forebrain, to control of the gonadotropic axis (Zhang et al, 1994 ).
Animal models offer several explanations and show that reduced leptin signaling leads to reduced GnRH neuronal activity; this may be due to decreased hypothalamic Kiss1 expression, a potent regulator of GnRH/LH/FSH release. The Kiss1 system participates in transmitting metabolic information to the GnRH neurons, thus providing a bridge between metabolic regulation and fertility. Infertility in overweight/obese males may be explained by leptin insensitivity. This implies a possible role for the KISS1 system in human obesity-related male infertility (Zhang et al, 1994) .
Glucose Homeostasis
RT-PCR and Immunohistochemistry were used to detect expression of KISS1 and GPR54 mRNAs and the production of KISS1 and GPR54 in human and mouse islets and in beta (MIN6) and alpha-(alphaTC1) cell lines (Hauge-Evans et al, 2006), but were not detected in the exocrine pancreas. Exposure of mouse and human islets to KISS1 caused a stimulation of glucose-induced (20 mmol/l) insulin secretion, in contrast, KISS1 inhibited insulin secretion from MIN6 cells at both 2 and 20 mmol/l glucose and had no significant effect on glucagon secretion from mouse islets, this shows that the GPR54/KISS1 system is expressed in the endocrine pancreas, where it influences beta cell secretory function.
Anti-oxidant Effect
The activities of catalase, superoxide dismutase (SOD), xanthine oxidase (XO), adenosine deaminase (AD) and level of malondialdehyde were studied in liver tissue. Serum samples were separated for total antioxidant capacity (TAC), total oxidant status (TOS), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, blood urea nitrogen (BUN), cholesterol, high-density lipoprotein (HDL) and triglyceride. Kisspeptin was seen to increase the activities of SOD and catalase (Aydin et al, 2010) . SOD is an oxido-reductase which catalyzes the dismutation of the superoxide anion into molecular oxygen and hydrogen peroxide. CAT detoxifies hydrogen peroxide, CAT is a well-known antioxidative enzyme and has been implicated in protection against hydrogen peroxide, and their localization is limited to the peroxisome (Aydin et al, 2010) .
Regulates Prolactin Release
Szawka et al. investigated kisspeptin's action in the control of secretion of hypothalamic dopamine (DA) and pituitary prolactin (PRL) in adult rats (Szawka et al, 2010) . Using the double-label immunofluorescence combined with confocal microscopy, KISS-IR fibers were shown to be in close apposition to hypothalamic dopamine (DA) perikarya in the arcuate nucleus, indicating that the kisspeptin neurons likely communicate with the DA (hypothalamic dopamine) neurons that regulate PRL (prolactin). The mechanism of the Prolactin (PRL) regulation occurs directly at the level of the tuberoinfundibular dopaminergic (TIDA) neurons located in the arcuate nucleus. The hypothalamic tuberoinfundibular dopaminergic (TIDA) neurones secrete dopamine, which inhibits prolactin secretion (Khodr et al, 2009 ). Kisspeptin was found to reduce c-Fos expression in TIDA neurons leading to the suppression of TIDA activity and consequently decreases prolactin release thereby regulating its release.
Hot Flushes in Post-Menopausal Women
A hot flush is characterized by episodic activation of heat dissipation effectors, including cutaneous vasodilatation, sweating, and behavioral thermoregulation (Freedman, 2012) .
Hot flushes are closely timed with luteinizing hormone (LH) pulses, thereby linking it to the hypothalamic neural circuitry controlling pulsatile gonadotropin-releasing hormone (GnRH) secretion (Casper et al, 1979) . Current evidence suggests that pulsatile GnRH secretion is modulated by a subpopulation of neurons in the arcuate (infundibular) nucleus that express estrogen receptor α (ERα), neurokinin 3 receptor (NK3R), kisspeptin, neurokinin B (NKB), and dynorphin . In the hypothalamus of postmenopausal women, these kisspeptin/NKB/ dynorphin (KNDy) neurons undergo an unusual somatic hypertrophy and express increased kisspeptin and NKB gene transcripts (Rance and Young, 1991) . Studies of cynomolgus monkeys indicate that the changes in KNDy neurons in postmenopausal women are secondary to withdrawal of ovarian estrogens and not due to aging per se (Rometo et al, 2007) . Consistent with this hypothesis, tract-tracing studies in the rodent showed that KNDy neurons project to structures critical for the regulation of body temperature (Krajewski et al, 2010) including the median preoptic nucleus (MnPO), an important component of a thermosensory heat-defense pathway (Nakamura et al, 2010) .
CLINICAL IMPLICATIONS
A homozygous substitution of leucine to serine at nucleotide 148 (L148S) or heterozygous mutations at nucleotides 331 (R331X) and 399 (X399R) (Seminara et al, 2003) , molecular analysis has shown the L148S mutation to inhibit the catalytic activation of Gq (G-protein). Fig. 6 shows the identified mutations in the human KISS1R gene which form the bases for pubertal and fertility disturbances (Seminara et al, 2003) .
Central Precocious Puberty
Precocious puberty is characterized by the development of secondary sexual characteristics before the age of eight years in girls and nine years in boys. The premature activation of GnRH secretion leading to central precocious puberty has remarkable female gender predominance. The relevance of the kisspeptin system in human puberty onset was highlighted by the identification of activating mutations of the KISS1R and KISS1 genes in children with central precocious puberty (Teles et al, 2008) . A unique, heterozygous, non-constitutively activating mutation of the KISS1R gene was associated with a central precocious puberty phenotype. In vitro studies demonstrated that this mutation leads to sustained activation of intracellular signaling pathways in response to kisspeptin. A gain-of-function mutation (R386P) was reported in a girl with central precocious puberty (Teles et al, 2008) .
Delayed Puberty
Kisspeptin as understood to be co-expressed with neurokinin B (NKB) and dynorphin, giving rise to the term KNDy neurons (Kisspeptin-Neurokinin B-Dynorphin). NKB is a member of the substance P-related tachykinin family and its receptor is expressed both on KNDy and GnRH neurons. Dynorphin is an opioid that participates in progesterone mediated negative feedback control of GnRH release. Loss-of-function mutations in the genes encoding neurokinin B (TAC3) and its receptor (TAC3R) result in hypogonadotrophic hypogonadism and pubertal failure (Topaloglu et al, 2009 ). Moreover, in sexually mature fish, kisspeptin treatment led to increased gonad weight, gonadosomatic index, and spermatocrit in some white and striped bass. Additionally, mature white bass treated with kisspeptins showed advancement in oocyte development as determined by histological examination. These gonadal changes occurred in the absence of any photothermal manipulation or hormone injections.
Gestational Trophoblastic Neoplasia (GTN)
Gestational trophoblastic neoplasia (GTN) is a disease occurring mainly in pregnant women. GTN comprises a number of disorders characterized by an abnormal proliferation of placental tissue (Palmieri et al, 2005) , but as has earlier been said of kisspeptin which increases during pregnancy, reduces trophoblast invasion therefore; a study was designed to determine whether plasma kisspeptin levels are altered in patients with malignant GTN. Blood samples were taken from patients with malignant GTN, it was found that kisspeptin IR was elevated in patients with malignant GTN; which was positively correlated with plasma hCG levels (Janneau et al, 2002) , therefore GTN is presently diagnosed by measuring hCG. Chemotherapy treatment reduced kisspeptin IR and hCG levels in each patient (Palmieri et al, 2005) . 
Summary and Conclusion
In the course of this review, KISSPEPTIN a novel peptide has been given a special focus; the role of kisspeptins in the body cannot be over emphasized. Kisspeptin, a neuropeptide formerly known as metastin is a protein that is encoded by the KISS1 gene. It is found mainly in the Anteroventral periventricular nucleus (AVPV) and Arcuate nucleus (ARC) nuclei of the hypothalamus. Kisspeptin and its receptor, G-protein receptor 54 form a complex which mediates the onset of puberty and the maintenance of reproductive function throughout life. It carries out this function mainly by triggering the release of GnRH from the hypothalamus which leads to the release of gonadotrophins (FSH and LH) which are the main mediators of physiological and anatomical changes indicating the onset of puberty. KISS1 gene originally was identified as a human metastasis suppressor gene because of its ability to suppress melanoma, therefore it has also been found to suppress cancer cell invasion and migrations especially in breast and prostate cancers. Kisspeptin has also been found to have functions in other organs of the body, stimulating insulin secretion in the pancreas, acting as anti-oxidant especially in the liver, regulation of prolactin, aiding placentation and implantation in pregnancy, and increasing sensitivity of chemoreceptors in the type-1cells of the carotid bodies. The research on kisspeptin is still in an early phase, and scientists believe that cell line and primary cultures from both central and peripheral tissues should provide a lot of missing information encountered in the course of reviewing this important peptide.
